---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-039651"
form_type: "8-K"
ticker: "PALI"
cik: "0001357459"
company_name: "PALISADE BIO, INC."
filed_at: "2023-11-07T23:59:59+00:00"
generated_at: "2026-06-08T14:11:08.481122+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "low"
source: SEC EDGAR
---

# Palisade Bio updates corporate presentation; no material new information disclosed

## Summary
- Palisade Bio filed an 8-K on November 7, 2023, attaching an updated corporate presentation.
- No specific financial or operational metrics were provided in the filing or available exhibit text.
- The presentation is accessible on the company's website under the Investors section.
- No changes to guidance, pipeline, or financial condition were announced.

## SEC filing metadata
- accession: 0001493152-23-039651
- form_type: 8-K
- ticker: PALI
- cik: 0001357459
- company_name: PALISADE BIO, INC.
- filed_at: 2023-11-07T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1357459/000149315223039651/0001493152-23-039651-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1357459/000149315223039651/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-039651
- JSON: https://secwatch.observer/filing/0001493152-23-039651.json
- Plain text: https://secwatch.observer/filing/0001493152-23-039651.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.